Healthia : Proposed issue of securities - HLA

Proposed issue of securities

Announcement Summary

For personal use only

Entity name

HEALTHIA LIMITED

Announcement Type

New announcement

Date of this announcement

19/11/2021

The Proposed issue is:

A placement or other type of issue

Total number of +securities proposed to be issued for a placement or other type of issue

		Maximum Number of
ASX +security code	+Security description	+securities to be issued
New code to be confirmed	PERFORMANCE RIGHTS - NEW	268,500

Proposed +issue date

19/11/2021

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 6

Proposed issue of securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of +Entity

HEALTHIA LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2	Registered Number Type	Registration Number
ABN	85626087223
1.3	ASX issuer code
HLA

1. The announcement is New announcement
2. Date of this announcement

19/11/2021

1.6 The Proposed issue is:

A placement or other type of issue

Proposed issue of securities

2 / 6

Proposed issue of securities

Part 7 - Details of proposed placement or other issue

only
	Part 7A - Conditions
		7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other
		type of issue can proceed on an unconditional basis?
		Yes
use	7A.1a Conditions
Approval/Condition	Date for determination	Is the date estimated or	** Approval
		+Security holder approval	17/11/2021	actual?	received/condition met?
		Actual
						Yes
		Comments
		Security holder was obtained at the Company's Annual General Meeting held 17 November 2021, to issue performance
personal	rights to Directors pursuant to the Company's Performance Rights Plan (the "Plan") (of which the Plan was approved by
shareholders at the Company's Annual General Meeting on 20 November 2019).
	Part 7B - Issue details
		Is the proposed security a 'New	Will the proposed issue of this
		class' (+securities in a class that is	+security include an offer of
		not yet quoted or recorded by ASX)	attaching +securities?
		or an 'Existing class' (additional	No
		securities in a class that is already

quoted or recorded by ASX)? Existing class

Details of +securities proposed to be issued

For

ASX +security code and description

HLAAA : PERFORMANCE RIGHTS

Number of +securities proposed to be issued

268,500

Offer price details

Are the +securities proposed to be issued being issued for a cash consideration?

No

Proposed issue of securities

3 / 6

Proposed issue of securities

Please describe the consideration being provided for the +securities

Performance Rights form part of Directors' remuneration and are issued for nil consideration.

Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?

only		No
	If some of the issued +securities do not rank equally
	Is the actual date from which the +securities will rank equally (non-ranking	Provide the actual non-ranking end
	end date) known?	date
use		Yes	31/12/2024
	Please state the extent to which the +securities do not rank equally:
			In relation to the next dividend, distribution or interest payment; or
			For any other reason
			The performance rights do not rank equally with existing ordinary shares quoted. Prior to vesting, the performance rights
			do not carry a right to vote or receive dividends.
personal		Where shares are issued upon the vesting and exercise of the performance rights, those shares will rank equally with
	existing ordinary shares of Healthia Limited.
			To participate in a dividend, the ordinary shares must be issued prior to the record date for the dividend.
	Part 7C - Timetable
		7C.1 Proposed +issue date
		19/11/2021
	Part 7D - Listing Rule requirements

For

7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? Yes

7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1

17/11/2021

7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? Yes

Proposed issue of securities

4 / 6

Proposed issue of securities

7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?

No

7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No

only
	Part 7E - Fees and expenses
		7E.1 Will there be a lead manager or broker to the proposed issue?
		No
use	7E.2 Is the proposed issue to be underwritten?
No
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
personal	Nil
	Part 7F - Further Information
		7F.01 The purpose(s) for which the entity is issuing the securities
		Issue of performance rights to Directors pursuant to the Company's Performance Rights Plan, which was approved by
		shareholders at the Annual General Meeting on 20 November 2019.
		7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?
		No
		7F.2 Any other information the entity wishes to provide about the proposed issue
		Conditions and Important Dates
		The vesting date for the 2021 Performance Rights will be 18 November 2024 (Vesting Date), subject to meeting the
For	Vesting Conditions and Service Conditions (set out below). The 2021 Performance Rights will expire on 31 December
2024, if not exercised, lapsed or forfeited earlier.
Vesting Conditions
		The Performance Rights which will vest in accordance with the Performance Rights Plan Rules is dependent on, and
		subject to, satisfaction of the following conditions:
		(a) Service Condition
		The Performance Rights will be exercisable upon satisfaction of the Service Condition, being continuous employment with
		the Company from the Grant Date until the Vesting Date.
		(b) EPS Growth Condition
		The Company's compounding annual growth in underlying Earnings Per Share (underlying EPS) for the period from 1 July
		2021 to 30 June 2024 must be greater than 10% per annum.
	Proposed issue of securities	5 / 6